arrow

About Curosurf

spacer band  
spacer

 

Curosurf® (poractant alfa) is an intratracheal suspension used by healthcare professionals for the prevention and treatment of Respiratory Distress Syndrome (RDS) in premature infants. The active ingredient of this natural surfactant is the phospholipid fraction obtained from porcine lung.

In adults, but also in term babies, surfactant lines the lungs and stops them from sticking together making normal breathing possible. However premature babies can be born with little or no surfactant, and develop RDS. Nowadays many hospitals give babies born at less than 30 weeks’ gestation age surfactant at birth because it can increase their chances of survival.

Curosurf® is a natural surfactant developed by Chiesi Farmaceutici, S.p.A. , Parma – Italy, in the early 1990s and is now marketed throughout the world in over 40 different countries. It works in the same way as the baby's own surfactant would have done and, therefore, will help the baby to breathe normally until the baby produces his own surfactant.

The introduction of surfactant replacement therapy has contributed to the dramatic decrease of mortality in the premature: in the 1980s (prior to surfactant) a baby born around 28 week gestational age had a 50-70% survival rate whilst nowadays that same baby has a 90% chance of survival. For those born as early as 24 weeks surfactant, along with other improvements in the neonatal care, has resulted in improvements in survival but to a lesser extent.

If a baby is at risk of RDS it is important that a surfactant is given either as a preventative treatment as soon as possible after birth or alternatively, as soon as RDS has been diagnosed, the neonatologist will decide how much is necessary.

Since its first introduction in 1992 it has been estimated that more than 400,000 premature babies have been treated with Curosurf®. Good clinical results together with an excellent safety profile has made surfactant replacement therapy with Curosurf® a well established treatment.

print

Patient information leaflet

List of countries where Curosurf is available

print